Does TACROLIMUS Cause Off label use? 8,718 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8,718 reports of Off label use have been filed in association with TACROLIMUS (Tacrolimus). This represents 9.6% of all adverse event reports for TACROLIMUS.
8,718
Reports of Off label use with TACROLIMUS
9.6%
of all TACROLIMUS reports
1,378
Deaths
3,230
Hospitalizations
How Dangerous Is Off label use From TACROLIMUS?
Of the 8,718 reports, 1,378 (15.8%) resulted in death, 3,230 (37.0%) required hospitalization, and 735 (8.4%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 8,718 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
Death (2,762)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TACROLIMUS Alternatives Have Lower Off label use Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB